Abstract:BACKGROUNDThe cardiometabolic syndrome comprised of multiple correlated traits, but its origin is incompletely understood. Chromogranin A (CHGA) is required for formation of the catecholamine secretory pathway in sympathochromaffin cells. In twin pair studies, we found that CHGA traits aggregated with body mass index (BMI), as well as its biochemical determinant leptin.METHODSHere we used the twin method to probe the role of heredity in generating such risk traits, and then investigated the role of risk-trait-associated CHGA promoter genetic variation in transfected chromaffin cells. Trait heritability (h(2)) and shared genetic determination among traits (pleiotropy, genetic covariance, PG) were estimated by variance components in twin pairs.RESULTSCHGA, BMI, and leptin each displayed substantial h(2), and the traits also aggregated with several features of the metabolic syndrome (e.g., insulin resistance, blood pressure (BP), hypertension, catecholamines, and C-reactive protein (CRP)). Twin studies demonstrated genetic covariance (pleiotropy, rho(G)) for CHGA, BMI, and leptin with other metabolic traits (insulin resistance, BP, and CRP). We therefore investigated the CHGA locus for mechanisms of codetermination with such metabolic traits. A common functional variant in the human CHGA promoter (G-462A, rs9658634, minor allele frequency similar to 21%) was associated with leptin and CRP secretion, as well as BMI, especially in women; marker-on-trait effects on BMI were replicated across twin populations on two continents. In CHGA promoter/luciferase reporter plasmids transfected into chromaffin cells, G-462A alleles differed markedly in reporter expression. The G-462A variant disrupted predicted transcriptional control by a PPAR gamma/RXR alpha motif and costimulation by PPAR gamma/RXR alpha and their cognate ligands, differentially activated the two alleles. During chromatin immunoprecipitation, endogenous PPAR gamma bound the motif.CONCLUSIONSMultiple features of the metabolic syndrome are thus under joint (pleiotropic) genetic determination, with CHGA as one such contributory locus:a common polymorphism in the promoter (G-462A) of CHGA predicts such heritable metabolic traits as BMI and leptin. CHGA promoter variant G-462A was not only associated with such metabolic traits but also disrupted a PPAR gamma/RXR alpha motif and responded differentially to characteristic trans-activators of that motif. The results suggest novel links between the catecholaminergic system and risk for the metabolic syndrome as well as systemic hypertension.

Heredity Of Endothelin Secretion - Human Twin Studies Reveal The Influence Of Polymorphism At The Chromogranin A Locus, A Novel Determinant Of Endothelial Function

Heredity of Endothelin Secretion

Genetic Variation Within a Metabolic Motif in the Chromogranin A Promoter: Pleiotropic Influence on Cardiometabolic Risk Traits in Twins

Naturally Occurring Genetic Variants in Human Chromogranin A (CHGA) Associated with Hypertension As Well As Hypertensive Renal Disease

Soluble Guanylate Cyclase Contribute Genetic Susceptibility To Essential Hypertension In The Han Chinese Population

Genetic Variation at the Delta-Sarcoglycan (SGCD) Locus Elevates Heritable Sympathetic Nerve Activity in Human Twin Pairs.

Proteomic Analysis Yields an Unexpected Trans-Acting Point in Control of the Human Sympathochromaffin Phenotype.

Naturally Occurring Human Genetic Variation in the 3′-Untranslated Region of the Secretory Protein Chromogranin A is Associated with Autonomic Blood Pressure Regulation and Hypertension in a Sex-Dependent Fashion

Chromogranin A Polymorphisms Are Associated with Hypertensive Renal Disease.

Identification of Novel Loci Affecting Circulating Chromogranins and Related Peptides

Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis.

Molecular Mechanism for Hypertensive Renal Disease

Catecholamine Storage Vesicles: Role of Core Protein Genetic Polymorphisms in Hypertension.

Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.

A Common Genetic Variant in the 3 '-Utr of Vacuolar H+-Atpase Atp6v0a1 Creates A Micro-Rna Motif to Alter Chromogranin A Processing and Hypertension Risk

Association of Endothelin-1 Gene Polymorphisms with the Clinical Phenotype in Primary Nephrotic Syndrome of Children.

Heritable Influence of DBH on Adrenergic and Renal Function: Twin and Disease Studies

Effect of genetic factors on target organ damage in patients with essential hypertension

Association of +138I/D and Lys198Asn Polymorphisms in the Endothelin-1 Gene with Early Onset of Coronary Artery Disease among the Chinese Han Population

A1166c Genetic Variation of the Angiotensin Ii Type I Receptor Gene and Susceptibility to Coronary Heart Disease: Collaborative of 53 Studies with 20,435 Cases and 23,674 Controls

Abstract 501: Endothelin-1 Expression Is Dependent On The Stability Of Endothelial Glycocalyx Heparan Sulfate